BioCentury
ARTICLE | Clinical News

Tracleer bosentan: Phase IV data

March 24, 2014 7:00 AM UTC

The double-blind, international Phase IV COMPASS-2 trial in about 334 patients with symptomatic PAH who were receiving sildenafil for >=12 weeks prior to randomization showed that add-on treatment wit...